Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID19 Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT04951323
What this trial is testing

Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)

Who this might be right for
Coronavirus Disease 2019 (Covid19)Hematopoietic Neoplasms
University of Liege 50
Not applicableStudy completedNCT04748172
What this trial is testing

COVID-19 Vaccine and Ovarian Reserve

Who this might be right for
Fertility IssuesVaccine Adverse Reaction
Sheba Medical Center 200
Large-scale testing (Phase 3)UnknownNCT06175494
What this trial is testing

Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Booster Vaccination With Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell)

Who this might be right for
COVID-19
WestVac Biopharma Co., Ltd. 4,800
Not applicableStudy completedNCT05866237
What this trial is testing

COVID-19 Vaccine Uptake Amongst Underserved Populations in East London

Who this might be right for
COVID-19InfluenzaVaccination Refusal
Queen Mary University of London 5,903
Not applicableLooking for participantsNCT06469788
What this trial is testing

Testimonials and Navigation in Rheumatology

Who this might be right for
Rheumatologic DiseaseAutoimmune Diseases
University of Alabama at Birmingham 1,170
Testing effectiveness (Phase 2)Study completedNCT04930003
What this trial is testing

Reactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 Vaccine

Who this might be right for
Covid19SARS-CoV InfectionVaccine Adverse Reaction
Research Institute for Biological Safety Problems 244
Large-scale testing (Phase 3)Active Not RecruitingNCT05658523
What this trial is testing

COVID-19 Booster Study in Healthy Adults in Australia

Who this might be right for
COVID-19
Murdoch Childrens Research Institute 496
Early research (Phase 1)Study completedNCT05113862
What this trial is testing

A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against SARS-CoV-2

Who this might be right for
CoronavirusSARS-CoV-2 InfectionCOVID-19
Gylden Pharma Ltd 26
Post-approval studies (Phase 4)UnknownNCT05148949
What this trial is testing

Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients

Who this might be right for
COVID-19Pulmonary Tuberculosis
Jiangsu Province Centers for Disease Control and Prevention 240
Early research (Phase 1)Study completedNCT06026514
What this trial is testing

Phase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in Adults

Who this might be right for
SARS-CoV-2 Infection
National Institute of Allergy and Infectious Diseases (NIAID) 27
Not applicableUnknownNCT04765215
What this trial is testing

Investigation of the Effectiveness of CoronaVac Vaccine in Cancer Patients With Active Chemotherapy and Comparison With Healthy People.

Who this might be right for
Is the Coronovac Vaccine Effective in Patients Receiving Chemotherapy
Asoc. Prof. Erdoğan Selçuk Şeber 291
Large-scale testing (Phase 3)WithdrawnNCT04540393
What this trial is testing

AZD1222 Vaccine for the Prevention of COVID-19

Who this might be right for
COVID-19
AstraZeneca
Testing effectiveness (Phase 2)UnknownNCT05239806
What this trial is testing

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E in Population Aged ≥12 Years Previously Fully Vaccinated With Inactivated COVID-19 Vaccine

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 400
Testing effectiveness (Phase 2)Looking for participantsNCT06821126
What this trial is testing

Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy Adults

Who this might be right for
Healthy
ANRS, Emerging Infectious Diseases 238
Not applicableLooking for participantsNCT05571735
What this trial is testing

Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients

Who this might be right for
Covid-19 PandemicsTuberculosis
University of Oxford 133
Large-scale testing (Phase 3)UnknownNCT05236491
What this trial is testing

COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases

Who this might be right for
Rheumatoid ArthritisAutoimmune Rheumatologic DiseaseSystemic Lupus Erythematosus+6 more
Paul R Fortin 287
Not applicableStudy completedNCT04961385
What this trial is testing

Immunogenicity of the ChAdox1 n CoV-19 Vaccine With 12-dose Vial

Who this might be right for
Covid19VaccineImmunogenicity
Bangkok Metropolitan Administration Medical College and Vajira Hospital 60
Post-approval studies (Phase 4)Study completedNCT04953325
What this trial is testing

Immunogenicity and Safety of an Inactivated COVID-19 Vaccine

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd. 270
Testing effectiveness (Phase 2)Study completedNCT05028374
What this trial is testing

COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies

Who this might be right for
Multiple MyelomaAL AmyloidosisChronic Lymphocytic Leukemia
Barbara Ann Karmanos Cancer Institute 119
Early research (Phase 1)Active Not RecruitingNCT07221162
What this trial is testing

A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 140
Next Page